There is currently no other method to detect and quantify micro-structural abnormality in the brain at presymptomatic stages of dementia, which is one of the main reasons why all clinical trials of Alzheimer's test drugs keep failing one after another.
When a disease-modifying treatment is found using our technology (and practically impossible without it), the person who knows the status of their brain health will be the one to benefit most from the treatment before developing symptoms.
How will your tech enable a disease-modifying treatment? Is the hypothesis your tech is the first way we can even measure?
Are you using standard MRIs and just a layer of software, or do you require some sort of special physical device?
This is all curiosity btw; I love the idea. I used to work on software for confocal microscopy and protein melting curves (to be clear, two different labs) before selling out and working on ads.
Darmiyan folks, is this correct? If so, what are the implications for the utility of the test?
(No matter the answer it feels like this research is important -- thank you!)
> Roughly 97% sensitivity (3% false negative) and 85% specificity (15% false positive)
So with this information, the calcuation of Bayesian probability is as follows:
(0.97*0.016)/(0.97*0.016+0.15*0.984) = 0.095
So a 9.5% chance of actually getting Alzheimers within the following 15 years if Darmiyan's test is positive. I don't have much formal statistical training, so I'm all ears if I'm making a mistake in the calculation here.They also write the following:
> False positive here is not real false positive, as the software is detecting abnormality in people who are still cognitively normal.
Which is a terrible excuse - abnormality is only clinically relevant if it leads to disease. By this logic I can create the world's greatest test for cancer simply by saying that every given individual has cancer (100% sensitivity), and if they don't have it yet, they do carry the genetic abnormalities that will lead to cancer eventually - no "real false positives", right? Simply saying that "sooner or later, our test will prove correct" is not good enough here.
Founders of Darmyian: I commend your efforts in this space as a tool for research, and can potentially be very valuable for clinical trials. However, offering it to consumers as a screening tool when there are no proven preventative measures is - in my opinion - completely unethical and comes across as an attempt at trying to profit off fear mongering.
[1] https://news.ycombinator.com/item?id=15083617I have never seen anyone over 75 that does not have some kind of dementia. Zero. Alzheimers and Dementia will soon be one of the same classification. It's happening.
Nature is just telling us, you have to go. It will be incurable, it's painless. She's being nice to us. Yes treat it, of course, but we have to let go sometimes.
PS, I work with seniors. People have NO CLUE to what these people go through. Zero.
And NO one can face this question, eventually, we die. Know the millennials don't believe that. They can't even comprehend it death. But it's true. Really. And it's OK.
So live life as it should be. For ALL our days are numbered. Don't worry, be happy.
:-)
- not the same as dementia, and never will be [1]. Dementia is an umbrella term that includes many diseases (e.g.: Parkinson's, etc), whereas Alzheimer's is just one of the many specific diseases with its own causes, symptoms, and chances of developing a cure.
- not painless. Apart from increased physical pain sensitivity [2], there's endless emotional pain that impacts the patient and their loved ones [3].
The point you're making about the inevitability of death is valid, but it shouldn't lead to the conclusion that we should just accept Alzheimer's as an incurable disease - of all the ways that a loved one can pass away, many families I work with would agree that this may be one of the worst.
Having worked with thousands of end-of-life clients, I am surprised that the research funding for Alzheimer's is far lower than that for cancer, heart disease, and HIV/Aids. My assumption is that people's view of Alzheimer's is rooted in the old and incorrect perception that it's an inevitable and natural part of aging, sometimes referred to as "senility."
Today we know a lot more about Alzheimer's, and I would challenge anyone to point out why Alzheimer's is fundamentally incurable - it's just a matter of when, and I certainly hope we'll find a cure sooner than later.
[1] https://www.kindlycare.com/dementia-vs-alzheimers/ [2] http://www.psychiatryadvisor.com/neurocognitive-disorders/al... [3] https://www.kindlycare.com/still-alice-portrait-of-a-disease... [4] http://www.aarp.org/health/brain-health/info-2015/alzheimers...
> PS, I work with seniors.
My fiancee says something similar, but she's a resident in a hospital, so she tends to tag "... in the hospital" or "... in the ICU" on the end of that statement because she's not seeing a random sample of all >75-year-olds.
"At present, there is no definitive evidence to support that any particular measure is effective in preventing AD"[1].
"Now we have analyzed more than 3000 brain scans and our software’s predictions are 90% accurate." (original post)
"In the United States, Alzheimer prevalence was estimated to be 1.6% in 2000 both overall and in the 65–74 age group"[2]
I'm assuming the 3000 brain scans you're referring to is from individuals which progressed to Alzheimers, or at least a dataset with such individuals highly represented (if this were 3000 random individuals, at a 1.6% prevalence, that amounts to 48 individuals who eventually got Alzheimers).
So according to my calculation of Bayesian probability, with a 90% sensitivity (as I'm interpreting your comment), and a 1.6% prevalence in the population, a randomly screened individual with a positive test will only actually have a 12.8% chance of getting Alzheimers. So you'll be diagnosing lots of people so that they can have an impending Alzheimer's diagnosis hanging over their head for the remainder of their life without actually being able to do anything about it, and of this cohort just over 1 in 10 people will actually end up getting Alzheimers.
Please tell me you're only planning on offering this for researchers, and not actually going to try to get individuals screened? Or am i missing something about your value proposition?
Edit: fixed sensitivity vs. specificity error